Lilly's experimental drug cuts weight by nearly 21% in diabetes trial
LLY•Eli Lilly said its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.
1. Trial results
Eli Lilly said its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.
